雜志介紹

Frontiers In Bioengineering And Biotechnology雜志介紹

《Frontiers In Bioengineering And Biotechnology》是一本以English為主的開放獲取國際優(yōu)秀期刊，中文名稱生物工程和生物技術前沿，本刊主要出版、報道工程技術-MULTIDISCIPLINARY SCIENCES領域的研究動態(tài)以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學術信息交流，提高行業(yè)發(fā)展。該刊已被國際權威數(shù)據庫SCIE收錄，為該領域相關學科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為4.3，最新CiteScore 指數(shù)為8.3。

本刊近期中國學者發(fā)表的論文主要有：

• Glutamine coated titanium for synergistic sonodynamic and photothermal on tumor therapy upon targeted delivery

  Author: Zhang, Lina; Zhu, Pengfeng; Wan, Ting; Wang, Huaiyan; Mao, Zhilei

• A small-diameter vascular graft immobilized peptides for capturing endothelial colony-forming cells

  Author: Tang, Yaqi; Yin, Lu; Gao, Shuai; Long, Xiaojing; Du, Zhanhui; Zhou, Yingchao; Zhao, Shuiyan; Cao, Yue; Pan, Silin

• Glucose determination in human serum by applying inner filter effect quenching mechanism of upconversion nanoparticles

  Author: Chen, Xiaojiao; Yang, Zhiying; Chen, Qiong; Zhang, Youyu

• Current development of stretchable self-powered technology based on nanomaterials toward wearable biosensors in biomedical applications

  Author: Wang, Qianqian; Sun, Xu; Liu, Chen; Wang, Chunge; Zhao, Wenjie; Zhu, Zehui; Ma, Sainan; Zhang, Sheng

英文介紹

Frontiers In Bioengineering And Biotechnology雜志英文介紹

The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.

In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.